Sign in
WithdrawnNo phase

High Flow Nasal Cannula Rates in Pediatric Asthma

Key facts

Who runs it
University of Rochester
Where
Rochester, United StatesSee the 2 sites
Trial code
Status
Withdrawn
Started
15 Jan 2025
Ended
30 Sept 2026
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • "High Flow" High Flow Nasal Cannula
  • "Low Flow" High Flow Nasal Cannula
Record updated
27 March 2026
Why it stopped
No longer performing study due to lack of funding and protected research time by PI

Who can take part

Age
2 years to 17 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Age 2-17 years old with prior clinical diagnosis of asthma
  • Admitted to PICU on standard asthma therapy defined as continuous albuterol and systemic corticosteroids
  • Admitted to PICU on either COT or HFNC
  • Admitted to PICU from either Golisano Children's Hospital ED or as a transport from an outside hospital ED within 6 hours of initial presentation
  • PRAM score greater than or equal to 4 after completion of initial ED therapy

Who cannot take part

  • Admitted to the PICU on NIV or invasive mechanical ventilation
  • Admitted to the PICU from general floors or > 6 hours from initial presentation
  • Presence of a tracheostomy or baseline NIV requirement
  • Pregnancy
  • Immunocompromised State

Where in United States

  • University of Rochester / Golisano Children's HospitalRochester, United States
  • University of Rochester Medical CenterRochester, United States

About the trial

What the trial wants to find out

This is a randomized, open-label, 3-armed feasibility trial will examine conventional oxygen therapy (COT) vs high flow nasal cannula at 4L/min flow vs HFNC at 2L/kg/min flow (max 60L/min) in moderate to severe pediatric asthma exacerbations.

The 3 groups in the trial

  • Conventional Oxygen Therapy (COT)No study treatment, for comparison

    Conventional Oxygen Therapy (COT) is the standard way to deliver oxygen to hypoxemic pediatric patients during an acute asthma exacerbation. Continuous albuterol will be administered via an aerogen set-up (aerogen mask, aerogen ultra, and a vibrating mesh nebulizer). Oxygen tubing will be connected to the wall and run at 2L/min as per the aerogen manufacturer's instructions.

  • "Low Flow" High Flow Nasal Cannula at 4L/minTreatment being tested

    A Fisher Paykl humidifier will be used for high flow humidification along with a flow meter and oxygen blender. A vibrating mesh nebulizer will be connected between the flow meter and the humidifier as per routine practice. Oxygen flow will be set to 4L/min and patient will be fitted with appropriately sized nasal prongs.

    Treatment: "Low Flow" High Flow Nasal Cannula

  • "High Flow" High Flow Nasal Cannula at 2L/kg/min (max 60L/min)Treatment being tested

    A Fisher Paykl humidifier will be used for high flow humidification along with a flow meter and oxygen blender. A vibrating mesh nebulizer will be connected between the flow meter and the humidifier as per routine practice. Oxygen flow will be set to 2L/kg/min (max 60L/min) and patient will be fitted with appropriately sized nasal prongs.

    Treatment: "High Flow" High Flow Nasal Cannula

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
High Flow Nasal Cannula Rates in Pediatric Asthma Exacerbations: A Feasibility Study
Record updated
27 March 2026